TEI Biosciences Inc. announces the launch of its SurgiMend Collagen Matrix for Soft Tissue Reconstruction product. TEI has received 510 clearance from the U.S. Food and Drug Administration to market SurgiMend for expanded use in plastic and reconstructive surgery, including breast reconstruction, and for tendon augmentation, in addition to the previously cleared hernia repair and muscle flap …
More: continued here